Dr Phil Jones
Epidermal stem cells
Laboratory Location: Wellcome Trust Sanger Institute
The Jones Group uses transgenic models, advanced imaging, novel sequencing approaches and quantitative methods to define the critical evolutionary steps that lead to non-melanoma skin and oesophageal cancer, and test the ability of targeted therapies to reduce the risk of cancer development.
Current projects include:
- Mapping mutations in normal human tissues
- Modelling clonal evolution in pre-cancer
Phil Jones is Leader of the "Stem cells and Cancer" programme, MRC Cancer Cell Unit and is also a Consultant in Medical Oncology at Addenbrooke’s Hospital.